Albion Financial Group Abb Vie Inc. Transaction History

Albion Financial Group

$1.38 Billion
Q1 2025

A detailed history of Albion Financial Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Albion Financial Group holds 45,438 shares of ABBV stock, worth $8.44 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

45,438

Previous 45,218 0.49%

Holding current value

$8.44 Million

Previous $8.04 Million 18.48%

% of portfolio

0.69%

Previous 0.56%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$169.2 - $216.66 $37,224 - $47,665	220 Added 0.49%	45,438 $9.52 Million
Q4 2024 Jan 17, 2025	BUY	$164.99 - $203.87 $201,122 - $248,517	1,219 Added 2.77%	45,218 $8.04 Million
Q3 2024 Oct 09, 2024	BUY	$163.84 - $199.33 $207,421 - $252,351	1,266 Added 2.96%	43,999 $8.69 Million
Q2 2024 Jul 10, 2024	BUY	$154.79 - $180.76 $27,552 - $32,175	178 Added 0.42%	42,733 $7.33 Million
Q1 2024 Apr 19, 2024	BUY	$159.82 - $182.1 $4.81 Million - $5.49 Million	30,123 Added 242.3%	42,555 $7.75 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $1,457 - $1,813	-11 Reduced 0.09%	12,432 $1.67 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $35,407 - $42,462	-256 Reduced 2.02%	12,443 $2.01 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $13,152 - $15,085	-98 Reduced 0.77%	12,699 $1.7 Million
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $68,810 - $87,480	-500 Reduced 3.76%	12,797 $1.96 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $331,797 - $411,667	-2,514 Reduced 15.9%	13,297 $2.16 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $19,874 - $25,147	-185 Reduced 1.16%	15,811 $2.14 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $39,979 - $44,539	380 Added 2.43%	15,996 $1.8 Million
Q4 2020 Feb 19, 2021	BUY	$80.49 - $108.67 $88,941 - $120,080	1,105 Added 7.61%	15,616 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $142,610 - $167,377	1,660 Added 12.92%	14,511 $1.27 Million
Q2 2020 Aug 17, 2020	BUY	$73.37 - $98.18 $368,684 - $493,354	5,025 Added 64.21%	12,851 $1.26 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $163,765 - $248,288	2,539 Added 48.02%	7,826 $596,000
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $13,921 - $17,418	193 Added 3.79%	5,287 $468,000
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $31,490 - $37,860	-500 Reduced 8.94%	5,094 $386,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $4,628 - $5,447	60 Added 1.08%	5,594 $451,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,534	5,534 $401,000

Others Institutions Holding ABBV

# of Institutions

4,260

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $328B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.

Account

Albion Financial Group Abb Vie Inc. Transaction History